- Home
- / Pionyr Immunotherapeutics
Pionyr Immunotherapeutics
Total Funding
$345 M
Pionyr Immunotherapeutics Summary
Company Summary
- Overview
- Pionyr Immunotherapeutics discovers and develops biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases, such as cancer, or to dampen immune responses in autoimmune diseases.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- South San Francisco, CA, US | view all locations
- Website
- http://www.pionyrtx.com/
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Leonard Reyno, Executive Vice President and Chief Medical Officer
Carol Gallagher, Director
Larry Garrido, Senior Director, Facilities Operations
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
2 Tower Pl #800